Literature DB >> 9601620

Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura.

A D Ogilvie1, M B Russell, P Dhall, S Battersby, V Ulrich, C A Smith, G M Goodwin, A J Harmar, J Olesen.   

Abstract

Allelic variation of the human serotonin transporter gene (HSERT), a highly plausible candidate gene for susceptibility to migraine, was investigated in 266 individuals with migraine, including 173 having migraine without aura (MO), 94 having migraine with aura (MA), 18 with co-occurrence of MO and MA, plus 133 unaffected controls. The distribution of a polymorphism with different forms of a variable tandem number repeat (VNTR) in intron 2 were compared. The MO group had an over-representation of genotypes with two twelve repeat alleles (STin2.12) and a reduction of genotypes containing one ten repeat (STin2.10) compared to controls. The MA group showed a similar pattern, but also a trend towards an increase in genotypes containing the nine repeat allele of the VNTR (STin2.9). Genotypes containing this allele were found in 6.4% of the MA group compared to 2.3% of controls. The group with co-occurrence of MO and MA had a significantly different pattern of overall allele frequency distribution from controls, reflecting a reduction in genotypes containing the STin2.10 allele and a shift both to STin2.9 carriers and to STin2.12 homozygosity. These results support the view that susceptibility to MO and MA has a genetic component, that these disorders are distinct, and that genetic susceptibility may in some cases be associated with a locus at or near the serotonin transporter gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601620     DOI: 10.1046/j.1468-2982.1998.1801023.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  19 in total

Review 1.  Sex, gender, and pain: women and men really are different.

Authors:  R B Fillingim
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

3.  Genomewide significant linkage to migrainous headache on chromosome 5q21.

Authors:  Dale R Nyholt; Katherine I Morley; Manuel A R Ferreira; Sarah E Medland; Dorret I Boomsma; Andrew C Heath; Kathleen R Merikangas; Grant W Montgomery; Nicholas G Martin
Journal:  Am J Hum Genet       Date:  2005-07-28       Impact factor: 11.025

4.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.

Authors:  A MacKenzie; J Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 5.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

Review 6.  STin2 VNTR polymorphism in the serotonin transporter gene and migraine: pooled and meta-analyses.

Authors:  Markus Schürks; Pamela M Rist; Tobias Kurth
Journal:  J Headache Pain       Date:  2010-06-29       Impact factor: 7.277

7.  Increased serotonin transporter availability in the brainstem of migraineurs.

Authors:  Sigrid Schuh-Hofer; Matthias Richter; Lilli Geworski; Arno Villringer; Heike Israel; Rüdiger Wenzel; Dieter Ludwig Munz; Guy Arnold
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

8.  Lack of association between five serotonin metabolism-related genes and medication overuse headache.

Authors:  Sabina Cevoli; Nadia Marzocchi; Sabina Capellari; Chiara Scapoli; Giulia Pierangeli; Daniela Grimaldi; Federica Naldi; L Alberto Pini; Pasquale Montagna; Pietro Cortelli
Journal:  J Headache Pain       Date:  2010-02       Impact factor: 7.277

Review 9.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  A twin study of depression and migraine: evidence for a shared genetic vulnerability.

Authors:  Ellen A Schur; Carolyn Noonan; Dedra Buchwald; Jack Goldberg; Niloofar Afari
Journal:  Headache       Date:  2009-04-27       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.